2005
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. 2005, cd005055. PMID: 16235391, DOI: 10.1002/14651858.cd005055.pub2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMean pulmonary arterial pressurePulmonary hypertensive crisisCongenital heart diseaseLong-term mortalityHeart diseasePulmonary hypertensionHeart rateHospital stayArterial pressureNitric oxidePostoperative managementMethodologic qualityMethaemoglobin levelsNeurodevelopmental disabilitiesEfficacy of iNOUse of iNOCochrane Central RegisterPulmonary arterial pressureSystemic blood pressureSubgroup of patientsHigh methodologic qualityMajority of outcomesMarkers of toxicityConventional managementHypertensive crisis
1989
Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation.
Dworetz A, Moya F, Sabo B, Gladstone I, Gross I. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics 1989, 84: 1-6. PMID: 2740158, DOI: 10.1542/peds.84.1.1.Peer-Reviewed Original ResearchConceptsPersistent pulmonary hypertensionPulmonary hypertensionExtracorporeal membrane oxygenation therapyCorresponding survival figuresMembrane oxygenation therapyExtracorporeal membrane oxygenationRecords of infantsSurvival of infantsConservative therapyMembrane oxygenationOxygenation therapySurvival figuresRetrospective evaluationMortality rateHypertensionECMOTherapyPatientsInfantsConservative approachSurvivalEarly periodHyperventilationCriteriaMainstay